This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharmacompanies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.
At 99% of pharmacompanies, that's a huge no-no. On top of this, “the company also revealed that the Federal Trade Commission and the Securities and Exchange Commission had opened two new, separate investigations into the troubled biotech. At 99% of pharmacompanies, that’s a huge no-no.
In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. Gone are the days when print ads and in-person detailing alone could carry a brand. Moreover, PPC isnt just about Google Ads.
The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinicaltrials, supply chain security and shortages, and environmental impact.
The drug led to impressive blood sugar and body weight drops in clinicaltrials. The approval for tirzepatide—which Lilly will market under the brand name Mounjaro—isn’t for weight loss but Type 2 diabetes. Food and Drug Administration approved Eli Lilly’s novel treatment for diabetes. A matter of trust?
SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharmacompanies, according to Indegene. Your physician audience should be segmented by parameters that are important to the success of your brand.
Introduction In todays digital-first world, content marketing campaigns are no longer optional for pharmaceutical brands. Imagine content marketing as the heartbeat of a pharmabrands digital presence. So, how can pharmacompanies use content marketing to engage HCPs and patients effectively ? Lets dive in.
This strategic move transformed Actavis into one of the largest pharmacompanies globally, with a strong presence across branded, generic and over-the-counter (OTC) medicines. Following the merger, Actavis rebranded itself as Allergan, leveraging the strong recognition of Allergans brand.
Whether you’re a large pharmacompany or a small, emerging one, communication is key. Mark has developed the commercial strategy and leading market access, marketing and multi-channel sales teams at launch for a German biotech company, CO.DON AG, a specialized leader in cell therapies.
With millions of healthcare professionals (HCPs) and patients active on platforms like LinkedIn, Twitter, Facebook, and Instagram, pharmabrands can no longer afford to stay silent. Effective social media strategies allow pharmacompanies to: Build trust with HCPs and patients. Short video clips with expert insights.
In 2019, drugs within the oncology therapeutic area accounted for $143 billion in branded pharmaceutical sales, equalling approximately 20% of all global pharmaceutical sales, according to McKinsey. AION plans to provide funding to four to six biotech companies per year, beginning next year.
Among these, influencer marketing has emerged as a powerful tool for pharmacompanies seeking to build trust and foster engagement with their target audiences. By leveraging influencer networks, pharmaceutical brands can effectively convey their messages, promote their products, and ultimately improve patient outcomes.
It powers drug discovery, clinicaltrials, and operational performance. The number one complaint about commercial teams, according to studies of HCPs, is that they don’t add much value in the digital world because the information is readily available online or on the brand’s website,” adds Kurian. Swift Integration. “It
In many cases, pharmacompanies select a contract development and manufacturing organisation (CDMO) to develop products versus doing the work themselves for reasons related to cost, convenience, and capacity. PDF scale and reformulation challenge manufacturers. Innovative solutions to complex challenges.
However, we have found that working with these groups during the design of the clinicaltrial is far more beneficial. By building trust early on, the patients will feel part of the solution from the outset, and communities may begin to work alongside pharma to support the acceptance and approval of new products.
Digital advertising campaigns allow pharmaceutical brands to connect with their audiences at critical moments in the healthcare journey. How Digital Ads Are Changing Pharma Marketing Precision Targeting : AI and data analytics allow ads to be shown to HCPs based on specialty, prescribing behavior, and practice location.
Digital advertising campaigns allow pharmaceutical brands to connect with their audiences at critical moments in the healthcare journey. How Digital Ads Are Changing Pharma Marketing Precision Targeting : AI and data analytics allow ads to be shown to HCPs based on specialty, prescribing behavior, and practice location.
Consultations and clinicaltrials are often few and far between. This new information can help pharma increase adherence by improving the quality of treatment and creating patient-centred programs and materials. More frequent data points are needed to get the whole picture on rare diseases.
But how can pharmabrands optimize their digital assets while staying compliant with industry regulations? Imagine a pharma website as a digital waiting room. By refining user experience, messaging, and engagement strategies, pharmacompanies can increase prescription intent, patient adherence, and HCP interaction rates.
Today, digital platforms like LinkedIn and Instagram connect brands with healthcare professionals (HCPs) and patients alike. Patient-Centric Approaches: The shift towards patient empowerment has revolutionized the way pharmabrands communicate. How can pharmacompanies personalize their campaigns?
Understanding Cost-Per-Action in Pharma Cost-Per-Action (CPA) is a performance-based advertising model where advertisers pay only when a specific action is completed. How It Works: Pharmacompanies define an “action,” such as an HCP downloading a clinical study or a patient enrolling in a treatment program.
Although they have, by definition, small addressable markets, the treatments cost just as many resources to develop as therapies for more common diseases – sometimes more, because of the added difficulty of finding sufficiently large patient populations for trials and finding disease experts to run them. How big pharma tackles rare diseases.
Despite limited clinical evidence, a higher inclination of patients towards marijuana has caused several pharmacompanies and regulatory authorities to look at the medical use of marijuana in a new light. Moreover, now BioSteel has signed Kansas City Chiefs quarterback Patrick Mahomes as the endorser of the brand.
According to Real Chemistry, there are currently 119 active GLP-1 agonist clinicaltrials, with 53 in Phases III or IV, across more than 60 potential new indications for GLP-1 treatment.
A marketing network refers to the interconnected channels and strategies pharmacompanies use to reach their target audiences. Why it Matters Efficient Reach: A well-structured network ensures that branded drugs like Keytruda or Dupixent are promoted effectively to the right audience.
These technologies enable pharmaceutical companies to analyze vast amounts of data quickly, identify potential drug candidates, and optimize clinicaltrials, ultimately accelerating the time-to-market for new therapies. Content marketing is another powerful tool in the pharma marketer’s arsenal.
Pharmacompanies face many challenges when involving patients in the design of clinicaltrials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.
Metoclopramide , sold under the brand name Reglan , is the first and only FDA-approved therapy for the treatment of Diabetic Gastroparesis. Prokinetic agents such as metoclopramide , domperidone , and erythromycin, increase the rate of gastric emptying and decrease symptoms in patients with Gastroparesis. Another U.S.
Chronic fatigue fibromyalgia, ADD, ADHD, and service those patients through a series of national clinics. Mark (83Bar): Yea and I was almost in service to clinics like Bob’s. My background for decades now is in the pharma marketing and branding space, working with all sorts of pharma products, devices, diagnostics.
Last year, the company added clinicaltrials to the list with the launch of CVS Health ClinicalTrial Services , an initiative that works with pharmacompanies on clinicaltrial recruitment and even hosts trial sites at certain retail locations. Take us back to May 2020.
So where to start… Congresswoman Porter may want to look at the percentage of generic drugs available virus branded (89%). I have worked with and stayed in contact with some R&D people within pharma and they have a different answer. In pharma R&D returns have declined to 1.8 percent—a slight decrease of 0.1
Rewind to March of 2020, and pharmacompanies were facing a communication crisis. Thankfully, many pharmacompanies had already started on a journey towards digital engagement, and healthcare professionals (HCPs) are embracing the medium more than ever before, thanks in part to newer generations who are increasingly digitally-savvy.
The drug is currently in clinicaltrials for alcoholic hepatitis (AH), nonalcoholic steatohepatitis (NASH), as well as in COVID-19 patients with acute liver or kidney injury. I personally and strongly feel this is a completely brand new and extremely powerful way of doing this,” says Dr. Rodgers. Key Moments.
With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. He notes that it already has 21 partnerships with pharmacompanies and will aim to keep more product rights than it did in the past.
In addition, both companies would be able to focus on maximising value creation for their shareholders by prioritising capital and resource allocation, employing separate capital structure policies, and increasing management focus on their respective business needs.”. The company had revenues of $9.6bn both in 2020 and last year.
How do you position your brand as a force for good while addressing public concerns? Think of Big Pharma as a lighthouse: its purpose is to guide and protect, but if the light isn’t clear, it can be misinterpreted. The company shared real-time updates about vaccine development, clinicaltrial results, and manufacturing timelines.
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharmacompanies in the world: AstraZeneca.
While not a record-breaking deal at $17 billion, the buyout strengthened Pfizer’s injectables business unit with the company reporting an 11 percent increase in revenue the following year. In addition, these drugs can be more complex to develop and push through the clinicaltrials process, causing R&D costs to add up quickly.
Recently, the Europe commission approved Bulevirtide (brand name Hepcludex) for the treatment of Hepatitis D after decades of research and trials. Several novel compounds are under different stages of a clinicaltrial as a treatment option for Hepatitis D.
This feeling contributes to a deep mistrust in both specific branded medications and the pharmaceutical industry producing those medications. Another factor that impacts trust in pharmaceutical companies is the discrepancy between the efficacy of medications in controlled clinicaltrials and their effectiveness in real-world use.
Pharmaceutical companies may deal in both generic and brand-name drugs as well as medical devices. There are 23 therapies and vaccines in total that are in Phase II of clinicaltrials. They are governed by a number of rules and regulations that govern drug patenting, testing, safety, efficacy, and marketing. .
We’re seeing everything from over-the-counter cold medication to cosmetic injection brands leverage different tiers of influencers. There is an opportunity for pharma to collaborate with these HCPs and patients, not just for sponsored content and patient education, but also to gather their unique insights around their disease or specialty.
After the war, Pfizer continued to focus on industrial chemicals as much as medicines, producing the citric acid needed for the emerging soft drinks industry, fuelling brands like Coca Cola and Dr Pepper’s expansion in the 1880s. Despite some setbacks, Pfizer remains one of the biggest pharmacompanies in the world today.
report indicating that they accounted for half of the most viewed new brands. No Time to Wait’ Ad Campaign from BMS-Pfizer Features Basketball Legend Kareem Abdul-Jabbar for AFib Awareness As pharma TV advertising remained popular in 2023, so did partnerships between pharmacompanies and celebrities for disease and drug campaigns.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content